GB0908069D0 - Pharmaceutical compounds and compositions - Google Patents

Pharmaceutical compounds and compositions

Info

Publication number
GB0908069D0
GB0908069D0 GB0908069A GB0908069A GB0908069D0 GB 0908069 D0 GB0908069 D0 GB 0908069D0 GB 0908069 A GB0908069 A GB 0908069A GB 0908069 A GB0908069 A GB 0908069A GB 0908069 D0 GB0908069 D0 GB 0908069D0
Authority
GB
United Kingdom
Prior art keywords
compositions
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0908069A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GB0908069A priority Critical patent/GB0908069D0/en
Publication of GB0908069D0 publication Critical patent/GB0908069D0/en
Priority to MX2011008496A priority patent/MX2011008496A/en
Priority to EP10704973A priority patent/EP2398798A1/en
Priority to AU2010215261A priority patent/AU2010215261A1/en
Priority to KR1020117018786A priority patent/KR20110116030A/en
Priority to CN2010800078222A priority patent/CN102395586A/en
Priority to PE2011001509A priority patent/PE20120655A1/en
Priority to BRPI1005327A priority patent/BRPI1005327A2/en
Priority to MA34175A priority patent/MA33128B1/en
Priority to PCT/GB2010/050257 priority patent/WO2010094956A1/en
Priority to JP2011549680A priority patent/JP2012517992A/en
Priority to CA2752693A priority patent/CA2752693A1/en
Priority to EA201190119A priority patent/EA201190119A1/en
Priority to US13/201,716 priority patent/US8557797B2/en
Priority to SG2011058823A priority patent/SG174134A1/en
Priority to CN201310309129.6A priority patent/CN103483338A/en
Priority to TN2011000380A priority patent/TN2011000380A1/en
Priority to CL2011001977A priority patent/CL2011001977A1/en
Priority to IL214658A priority patent/IL214658A0/en
Priority to CO11103685A priority patent/CO6420344A2/en
Priority to ZA2011/05993A priority patent/ZA201105993B/en
Ceased legal-status Critical Current

Links

GB0908069A 2009-02-17 2009-05-11 Pharmaceutical compounds and compositions Ceased GB0908069D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GB0908069A GB0908069D0 (en) 2009-05-11 2009-05-11 Pharmaceutical compounds and compositions
CN201310309129.6A CN103483338A (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as p38 map kinase inhibitors
JP2011549680A JP2012517992A (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as P38 MAP kinase inhibitors
EA201190119A EA201190119A1 (en) 2009-02-17 2010-02-16 DERIVATIVES OF TRIAZOLOPIRIDINE AS MAR-KINASE INHIBITORS p38
AU2010215261A AU2010215261A1 (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as p38 MAP kinase inhibitors
KR1020117018786A KR20110116030A (en) 2009-02-17 2010-02-16 Triazolopyridine Derivatives as P3MMAP Kinase Inhibitors
CN2010800078222A CN102395586A (en) 2009-02-17 2010-02-16 Triazolopyridine Derivatives as P38MAP Kinase Inhibitors
PE2011001509A PE20120655A1 (en) 2009-02-17 2010-02-16 TRIAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINES ACTIVATED BY MITOGEN P38 (MAP)
BRPI1005327A BRPI1005327A2 (en) 2009-02-17 2010-02-16 triazolopyridine derivatives as p38 map kinase inhibitors
MA34175A MA33128B1 (en) 2009-02-17 2010-02-16 TRIAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF P38 MAP KINASE
PCT/GB2010/050257 WO2010094956A1 (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as p38 map kinase inhibitors
MX2011008496A MX2011008496A (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as p38 map kinase inhibitors.
CA2752693A CA2752693A1 (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as p38 map kinase inhibitors
EP10704973A EP2398798A1 (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as p38 map kinase inhibitors
US13/201,716 US8557797B2 (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives and their therapeutic use
SG2011058823A SG174134A1 (en) 2009-02-17 2010-02-16 Triazolopyridine derivatives as p38 map kinase inhibitors
TN2011000380A TN2011000380A1 (en) 2009-02-17 2011-08-03 Triazolopyridine derivatives as p38 map kinase inhibitors
CL2011001977A CL2011001977A1 (en) 2009-02-17 2011-08-12 Triazolopyridine derived compounds, p38 mitogen-activated protein kinase inhibitors; pharmaceutical composition; and its use for the treatment of chronic eosinophilic pneumonia, asthma, chronic obstructive pulmonary disease and respiratory distress syndrome in adults, among other diseases.
IL214658A IL214658A0 (en) 2009-02-17 2011-08-15 Triazolopyridine derivatives as p38 map kinase inhibitors
CO11103685A CO6420344A2 (en) 2009-02-17 2011-08-16 TRIAZOLOPIRIDINE DERIVATIVES AS INHIBITORS OF KINASE PROTEINS ACTIVATED BY MITOGEN P38 (MAP)
ZA2011/05993A ZA201105993B (en) 2009-02-17 2011-08-16 Triazolopyridine derivatives as p38 map kinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0908069A GB0908069D0 (en) 2009-05-11 2009-05-11 Pharmaceutical compounds and compositions

Publications (1)

Publication Number Publication Date
GB0908069D0 true GB0908069D0 (en) 2009-06-24

Family

ID=40833801

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0908069A Ceased GB0908069D0 (en) 2009-02-17 2009-05-11 Pharmaceutical compounds and compositions

Country Status (1)

Country Link
GB (1) GB0908069D0 (en)

Similar Documents

Publication Publication Date Title
ZA201107776B (en) Pharmaceutical composition
IL243015B (en) Multicyclic compounds and pharmaceutical compositions comprising them
SG2014012405A (en) Pharmaceutical compositions
GB0814695D0 (en) Pharmaceutical compositions
ZA201200054B (en) Therapeutic compounds and compositions
IL217912A (en) 5-amino-1- benzimidazole-pyrazole derivatives and pharmaceutical compositions comprising them
PT2323623T (en) Pharmaceutical compositions
EP2379077A4 (en) Pharmaceutical composition
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
IL247086A0 (en) Nitrogen-containing compounds and pharmaceutical compositions
ZA201200079B (en) Pharmaceutical compositions and solid forms
IL206487A0 (en) Pharmaceutical compositions
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL219018A0 (en) Pharmaceutical compositions
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0919650D0 (en) Pharmaceutical composition
GB0800659D0 (en) Pharmaceutical Compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions
GB0901241D0 (en) Pharmaceutical compositions
HU0900010D0 (en) Improved pharmaceutical composition
GB0908970D0 (en) Local pharmaceutical compositions
GB0806283D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)